CoChat

Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter—a review of current understanding of its mechanism of action

Zhong, Huailing, Haddjeri, Nasser, Sánchez, Connie · 2012 · Psychopharmacology

The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.

Abstract

Rationale Escitalopram is a widely used antidepressant for the treatment of patients with major depression. It is the pure S-enantiomer of racemic citalopram. Several clinical trials and meta-analyses indicate that escitalopram is quantitatively more efficacious than many other antidepressants with a faster onset of action.Objective This paper reviews current knowledge about the mechanism of action of escitalopram.Results The primary target for escitalopram is the serotonin transporter (SERT), which is responsible for serotonin (or 5-hydroxytryptamine [5-HT]) reuptake at the terminals and cell bodies of serotonergic neurons. Escitalopram and selective serotonin reuptake inhibitors bind with high affinity to the 5-HT binding site (orthosteric site) on the transporter. This leads to antidepressant effects by increasing extracellular 5-HT levels which enhance 5-HT neurotransmission. SERT also has one or more allosteric sites, binding to which modulates activity at the orthosteric binding site but does not directly affect 5-HT reuptake by the transporter. In vitro studies have shown that through allosteric binding, escitalopram decreases its own dissociation rate from the orthosteric site on the SERT. R-citalopram, the nontherapeutic enantiomer in citalopram, is also an allosteric modulator of SERT but can inhibit the actions of escitalopram by interfering negatively with its binding. Both nonclinical studies and some clinical investigations have demonstrated the cellular, neurochemical, neuroadaptive, and neuroplastic changes induced by escitalopram with acute and chronic administration.Conclusions The findings from binding, neurochemical, and neurophysiological studies may provide a mechanistic rationale for the clinical difference observed with escitalopram compared to other antidepressant therapies.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00213-011-2463-5

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 111 references

Research works printed but not linked: 1

  1. Loland CJ, Plenge P, Shi L, Zhang P, Javitch JA, Newman AH, Weinstein H, Gether U (2010) Mapping of the allosteric binding site in the serotonin transporter. Basic Clin Pharmacol Toxicol 107:116–117

Cited by

See all 127

Metadata

Authors
Zhong, H., Haddjeri, N., & Sánchez, C.
Affiliations
  • Lyon 1 Université (FR)
  • Lundbeck (United States) (US)
Corresponding author
Zhong, Huailing
Venue
Psychopharmacology
Published
2011-09-08
Volume
219
Issue
1
Pages
1-13
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2031385069
Cited by
105
References
111
Citations by year
2026: 6 · 2025: 8 · 2024: 8 · 2023: 7 · 2022: 8 · 2021: 8 · 2020: 4 · 2019: 4 · 2018: 9 · 2017: 4 · 2016: 10 · 2015: 10 · 2014: 9 · 2013: 7 · 2012: 3
FWCI
0.75
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Institut National de la Santé et de la Recherche Médicale
  • H. Lundbeck A/S
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
escitalopram, serotonin transporter, allosteric modulation, orthosteric binding site, selective serotonin reuptake inhibitors, major depressive disorder, antidepressant mechanism, serotonergic neurotransmission, neuroplasticity, neural adaptation
MeSH terms
Allosteric Regulation, Animals, Depressive Disorder, Humans, Citalopram, Selective Serotonin Reuptake Inhibitors, Antidepressive Agents, Second-Generation, Serotonin Plasma Membrane Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter—a review of current understanding of its mechanism of action. https://app.cochat.ai/papers/10.1007/s00213-011-2463-5
The paper
Zhong, H., Haddjeri, N., & Sánchez, C. (2012). Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter—a review of current understanding of its mechanism of action. Psychopharmacology. https://doi.org/10.1007/s00213-011-2463-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.